跳至主要内容
临床试验/JPRN-UMIN000050326
JPRN-UMIN000050326招募中Unknown

Cohort study of treatment strategy for low risk HER2 positive breast cancer based on response-guided therapy and shared decision making - HERREST study

Eiichi Shiba,the Department of Breast and Endocrine Surgery, Osaka Breast Clinic0 个研究点目标入组 100 人开始时间: 2023年3月1日最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1) Concurrent bilateral breast cancer, multiple ipsilateral breast cancers of different subtypes 2) History of breast cancer, active overlapping cancers, history of allergies that would result in protocol interruption 3) History of serious cardiac disease (heart failure, myocardial infarction, ischemic disease, vascular disease requiring treatment) 4) Difficulty in continuing hospital visits due to physical inactivity 5) Complicated mental illness or psychiatric symptoms that make participation in the study difficult 6) In case the attending physician determines that the subject is not suitable for participation in the study

研究者

发起方
Eiichi Shiba,the Department of Breast and Endocrine Surgery, Osaka Breast Clinic

相似试验

Cohort study of treatment strategy for low risk HER2... | 临床试验